Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.

Ariës IM, Bodaar K, Karim SA, Chonghaile TN, Hinze L, Burns MA, Pfirrmann M, Degar J, Landrigan JT, Balbach S, Peirs S, Menten B, Isenhart R, Stevenson KE, Neuberg DS, Devidas M, Loh ML, Hunger SP, Teachey DT, Rabin KR, Winter SS, Dunsmore KP, Wood BL, Silverman LB, Sallan SE, Van Vlierberghe P, Orkin SH, Knoechel B, Letai AG, Gutierrez A.

J Exp Med. 2018 Nov 7. pii: jem.20180570. doi: 10.1084/jem.20180570. [Epub ahead of print]

PMID:
30404791
2.

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.

Jerchel IS, Hoogkamer AQ, Ariës IM, Steeghs EMP, Boer JM, Besselink NJM, Boeree A, van de Ven C, de Groot-Kruseman HA, de Haas V, Horstmann MA, Escherich G, Zwaan CM, Cuppen E, Koudijs MJ, Pieters R, den Boer ML.

Leukemia. 2018 Apr;32(4):931-940. doi: 10.1038/leu.2017.303. Epub 2017 Oct 3.

3.

An X-linked tumor suppressor in T-ALL.

Ariës IM, Gutierrez A.

Blood. 2015 Jan 1;125(1):3-4. doi: 10.1182/blood-2014-11-607838. No abstract available.

4.

Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance.

Ariës IM, van den Dungen RE, Koudijs MJ, Cuppen E, Voest E, Molenaar JJ, Caron HN, Pieters R, den Boer ML.

Haematologica. 2015 Apr;100(4):e132-6. doi: 10.3324/haematol.2014.112995. Epub 2014 Dec 5. No abstract available.

5.

Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.

Warris LT, van den Heuvel-Eibrink MM, Ariës IM, Pieters R, van den Akker EL, den Boer ML.

Haematologica. 2015 Apr;100(4):e137-9. doi: 10.3324/haematol.2014.112177. Epub 2014 Nov 25. No abstract available.

6.

EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion.

Ariës IM, Jerchel IS, van den Dungen RE, van den Berk LC, Boer JM, Horstmann MA, Escherich G, Pieters R, den Boer ML.

Leukemia. 2014 Sep;28(9):1828-37. doi: 10.1038/leu.2014.80. Epub 2014 Feb 20.

PMID:
24625531
7.

The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.

Ariës IM, Hansen BR, Koch T, van den Dungen R, Evans WE, Pieters R, den Boer ML.

Haematologica. 2013 Dec;98(12):1905-11. doi: 10.3324/haematol.2013.093823. Epub 2013 Oct 18.

8.

The NR4A orphan nuclear receptors do not confer prednisolone resistance in pediatric acute lymphoblastic leukemia.

Ariës IM, van den Dungen ES, Pieters R, den Boer ML.

Leukemia. 2014 Feb;28(2):422-5. doi: 10.1038/leu.2013.275. Epub 2013 Sep 23. No abstract available.

PMID:
24056879
9.

MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

Akbari Moqadam F, Lange-Turenhout EA, Ariës IM, Pieters R, den Boer ML.

Leuk Res. 2013 Oct;37(10):1315-21. doi: 10.1016/j.leukres.2013.06.027. Epub 2013 Jul 31.

PMID:
23915977
10.

Tumor cells secrete galectin-1 to enhance endothelial cell activity.

Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, Griffioen AW.

Cancer Res. 2010 Aug 1;70(15):6216-24. doi: 10.1158/0008-5472.CAN-09-4150. Epub 2010 Jul 20. Erratum in: Cancer Res. 2012 Feb 1;72(3):825.

Supplemental Content

Loading ...
Support Center